Valuation: Danaher Corporation

Capitalization 139B 118B 109B 103B 191B 12,980B 196B 1,279B 503B 6,199B 520B 509B 22,142B P/E ratio 2026 *
30.4x
P/E ratio 2027 * 25.3x
Enterprise value 149B 127B 117B 111B 206B 13,937B 211B 1,373B 540B 6,656B 559B 547B 23,775B EV / Sales 2026 *
5.81x
EV / Sales 2027 * 5.37x
Free-Float
72.69%
Yield 2026 *
0.7%
Yield 2027 * 0.75%
1 day-0.72%
1 week+1.95%
Current month+3.31%
1 month+4.56%
3 months-16.85%
6 months-4.52%
Current year-14.44%
1 week 188.06
Extreme 188.06
198.56
1 month 181.01
Extreme 181.01
198.56
Current year 181.01
Extreme 181.01
242.8
1 year 180.03
Extreme 180.03
242.8
3 years 171
Extreme 171
281.7
5 years 171
Extreme 171
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2020
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1983
Director/Board Member 69 01/01/1983
Change 5d. change 1-year change 3-years change Capi.($)
+3.30%+1.95%+3.78%-23.01% 139B
+3.65%+5.33%+17.36%-13.01% 191B
+1.85%+1.41%-7.02%+72.18% 163B
+2.25%+0.94%-32.55%+22.68% 93.9B
+0.85%+5.90%-14.09%-28.86% 49.36B
+0.32%-3.78%+12.56%-7.73% 45.04B
+0.89%+4.87%+17.54%-10.98% 33.69B
+0.61%+2.37%+7.60%+1.64% 33.4B
+2.12%+2.32%+14.40%-16.83% 33.21B
+1.46%+6.77%-0.17%+3.94% 31.87B
Average +0.26%+1.86%+1.94%+0.00% 81.32B
Weighted average by Cap. +0.87%+1.34%+1.02%+7.01%

Financials

2026 *2027 *
Net sales 25.61B 21.88B 20.17B 19.04B 35.38B 2,398B 36.28B 236B 92.9B 1,145B 96.12B 94.08B 4,091B 27.08B 23.14B 21.33B 20.13B 37.41B 2,536B 38.36B 250B 98.24B 1,211B 102B 99.49B 4,326B
Net income 4.61B 3.94B 3.63B 3.43B 6.37B 432B 6.53B 42.54B 16.72B 206B 17.3B 16.94B 736B 5.69B 4.86B 4.48B 4.23B 7.86B 532B 8.05B 52.46B 20.63B 254B 21.34B 20.89B 908B
Net Debt 10.22B 8.73B 8.05B 7.6B 14.12B 957B 14.48B 94.29B 37.07B 457B 38.36B 37.54B 1,633B 6.94B 5.93B 5.47B 5.16B 9.59B 650B 9.84B 64.07B 25.19B 311B 26.06B 25.51B 1,109B
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
13/04/26 195.87 $ +3.30% 4,836,658
10/04/26 189.61 $ -1.75% 3,189,026
09/04/26 192.99 $ -1.63% 2,903,201
08/04/26 196.19 $ +2.71% 2,610,024
07/04/26 191.01 $ -0.58% 2,932,668
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
195.87USD
Average target price
258.64USD
Spread / Average Target
+32.04%

Quarterly revenue - Rate of surprise